Cargando…

Does the use of proton pump inhibitors increase the risk of hypomagnesemia: An updated systematic review and meta-analysis

BACKGROUND: Proton pump inhibitors (PPIs) are commonly used in the treatment of acid-related diseases; however, the association between the use of PPIs and potential risk of hypomagnesemia is controversial. METHODS: In the present study, databases including PubMed, EMBASE, MEDLINE, PsycINFO, CINAHL,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Shengtao, Gan, Li, Mei, Zhechuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6456119/ https://www.ncbi.nlm.nih.gov/pubmed/30921222 http://dx.doi.org/10.1097/MD.0000000000015011

Ejemplares similares

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Is hypomagnesemia associated with using proton pump inhibitors?
por: Yi, Joo-Hark, et al.
Publicado: (2016)

Mechanisms of proton pump inhibitor‐induced hypomagnesemia
por: Gommers, Lisanne M. M., et al.
Publicado: (2022)

Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia
por: Boerlage, Thomas C. C., et al.
Publicado: (2016)

Proton pump inhibitors and hypomagnesemia: A meta-analysis of observational studies
por: Srinutta, Thawin, et al.
Publicado: (2019)

The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia: A Systematic Review and Meta-Analysis
por: Park, Chan Hyuk, et al.
Publicado: (2014)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Proton-pump inhibitor use amongst patients with severe hypomagnesemia
por: Seah, Sherry, et al.
Publicado: (2023)

Prevalence and outcomes of proton pump inhibitor associated hypomagnesemia in chronic kidney disease
por: Hughes, John, et al.
Publicado: (2018)

Proton Pump Inhibitor-Induced Hypomagnesemia: A Rare, Potentially Fatal Complication
por: Pawlukiewicz, Alec J, et al.
Publicado: (2020)

Proton Pump Inhibitors and Hospitalization with Hypomagnesemia: A Population-Based Case-Control Study
por: Zipursky, Jonathan, et al.
Publicado: (2014)

Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication
por: Semb, Synne, et al.
Publicado: (2017)

Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic
por: Uehara, Atsuko, et al.
Publicado: (2019)

The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV
por: Sutton, S. Scott, et al.
Publicado: (2019)

Proton-pump Inhibitor Use and Fracture Risk: An Updated Systematic Review and Meta-analysis
por: Nassar, Yousef, et al.
Publicado: (2018)

Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease
por: Arj, Abbas, et al.
Publicado: (2022)

Hypomagnesemia Caused by Chronic Use of Over-the-Counter Proton Pump Inhibitor as a Possible Cause of Supraventricular Tachycardia
por: Ortega, Francisco J, et al.
Publicado: (2023)

Proton pump inhibitor use does not increase dementia and Alzheimer’s disease risk: An updated meta-analysis of published studies involving 642305 patients
por: Song, Ya Qi, et al.
Publicado: (2019)

Does the Use of Proton Pump Inhibitors Increase the Risk of Pancreatic Cancer? A Systematic Review and Meta-Analysis of Epidemiologic Studies
por: Hong, Hee-Eun, et al.
Publicado: (2020)

Inherited forms of renal hypomagnesemia: an update
por: Knoers, Nine V. A. M.
Publicado: (2009)

The regulatory roles of aquaporins in the digestive system
por: Liao, Shengtao, et al.
Publicado: (2020)

Proton Pump Inhibitor and Tacrolimus Uses are Associated With Hypomagnesemia in Connective Tissue Disease: a Potential Link With Renal Dysfunction and Recurrent Infection
por: Hanaoka, Hironari, et al.
Publicado: (2021)

Proton pump inhibitor use increases hepatic encephalopathy risk: A systematic review and meta-analysis
por: Ma, Yun-Jie, et al.
Publicado: (2019)

Proton pump inhibitors increase risk of COVID-19
Publicado: (2020)

Proton pump inhibitor use and risk of dementia: Systematic review and meta-analysis
por: Li, Min, et al.
Publicado: (2019)

Increased Risk of Fractures and Use of Proton Pump Inhibitors in Menopausal Women: A Systematic Review and Meta-Analysis
por: da Maia, Thuila Ferreira, et al.
Publicado: (2022)

Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways
por: Liao, Shengtao, et al.
Publicado: (2018)

Exposure to proton pump inhibitors and risk of diabetes: A systematic review and meta-analysis
por: Guo, Yun-Ran, et al.
Publicado: (2023)

Using proton pump inhibitors increases the risk of hepato-biliary-pancreatic cancer. A systematic review and meta-analysis
por: Zhou, Wence, et al.
Publicado: (2022)

Pharmacokinetic Drug Interaction Profiles of Proton Pump Inhibitors: An Update
por: Wedemeyer, Ralph-Steven, et al.
Publicado: (2014)

Proton Pump Inhibitors and Bone Health: An Update Narrative Review
por: Lespessailles, Eric, et al.
Publicado: (2022)

Increased Proton Pump Inhibitors−Induced Mortality Risk in Hemodialysis Patients
por: Sertorio, Jonas T., et al.
Publicado: (2018)

Proton pump inhibitors therapy and risk of Clostridium difficile infection: Systematic review and meta-analysis
por: Trifan, Anca, et al.
Publicado: (2017)

Proton Pump Inhibitors Use and Risk of Preeclampsia: A Meta-Analysis
por: Hussain, Salman, et al.
Publicado: (2022)

Proton Pump Inhibitors, Kidney Damage, and Mortality: An Updated Narrative Review
por: Edinoff, Amber N., et al.
Publicado: (2023)

Does proton pump inhibitors use increase risk of digestive tumors?: A 2-sample Mendelian randomization study
por: Zhao, Ruiqi, et al.
Publicado: (2023)

Randomised trials of proton pump inhibitors for gastro-oesophageal reflux disease in patients with asthma: an updated systematic review and meta-analysis
por: Zheng, Zhoude, et al.
Publicado: (2021)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
por: Arora, Pradeep, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_du3ial2k3h52tmg4ib3q4tg5ah